Showing session: reset
Early Detection Biomarkers: Aptamers, MIRs, and Autoantibodies
- Sort by:
- Browse by:
- Free
- audio + slides
- Some slides withheld
Detection of mesothelioma in asbestos exposed individuals with aptamer proteomic technology
Harvey I Pass
NYU Langone Medical Center and Cancer Center, New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Serum biomarker panel detects lung cancer in never smokers
Charlie Birse
Celera, Alameda, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Angiopoietin-like protein 3 is a novel biomarker and autoantigen in pre-diagnostic sera of non-small cell lung cancer patients
Allen D Taylor
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Free
- slides video
- audio + slides
- All slides included
Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA
Scott A Tomlins
Univ. of Michigan, Ann Arbor, MI, United States
- Permission not
granted for presentation
Discovery of a miRNA-based RT-qPCR signature able to detect early stage colorectal cancer in blood plasma
Adam Baker
Exiqon A/S, Vedbaek, Denmark
- Free
- slides video
- audio + slides
- All slides included
An RNA aptamer is a potential biomarker for pancreatic cancer
Partha Ray
Duke University, Durham, NC, United States
- Permission not
granted for presentation
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels
Christine M Coticchia
Children's Hospital Boston and Harvard Medical School, Boston, MA, United States